These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 19484202

  • 1. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, Klaushofer K, Austrian Society for Bone and Mineral Research (AuSBMR).
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.
    Prescrire Int; 2005 Feb; 14(75):5-9. PubMed ID: 15747448
    [Abstract] [Full Text] [Related]

  • 9. Anabolic therapy for osteoporosis.
    Bilezikian JP.
    Int J Fertil Womens Med; 2005 Feb; 50(2):53-60. PubMed ID: 16334411
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacotherapy of osteoporosis: evidence-based clinical practice].
    Fassbender WJ, Stumpf UC, Jockenhövel F.
    Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():173-7. PubMed ID: 16802548
    [Abstract] [Full Text] [Related]

  • 11. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S.
    Clin Ther; 2006 Feb 22; 28(2):151-73. PubMed ID: 16678639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Strategies for treatment to prevent fragility fractures in postmenopausal women.
    Geusens P.
    Best Pract Res Clin Rheumatol; 2009 Dec 22; 23(6):727-40. PubMed ID: 19945685
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Progress in the treatment of osteoporosis].
    Sugimoto T.
    Rinsho Byori; 2008 Oct 22; 56(10):887-93. PubMed ID: 19068785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
    Miller RG.
    Geriatrics; 2006 Jan 22; 61(1):24-30. PubMed ID: 16405361
    [Abstract] [Full Text] [Related]

  • 19. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S, Fukawa T, Kamiya S.
    Clin Calcium; 2007 Dec 22; 17(12):1888-94. PubMed ID: 18057665
    [Abstract] [Full Text] [Related]

  • 20. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ.
    Arthritis Rheum; 2008 Jun 22; 58(6):1687-95. PubMed ID: 18512789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.